The new platinum-based anticancer agent LA-12 induces retinol binding protein 4 in vivo

BACKGROUND: The initial pharmacokinetic study of a new anticancer agent (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum (IV) (LA-12) was complemented by proteomic screening of rat plasma. The objective of the study was to identify new LA-12 target proteins that serve as markers of LA-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouchal, Pavel, Jarkovsky, Jiri, Hrazdilova, Kristyna, Dvorakova, Monika, Struharova, Iva, Hernychova, Lenka, Damborsky, Jiri, Sova, Petr, Vojtesek, Borivoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221626/
https://www.ncbi.nlm.nih.gov/pubmed/22040120
http://dx.doi.org/10.1186/1477-5956-9-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221626/
https://www.ncbi.nlm.nih.gov/pubmed/22040120
http://dx.doi.org/10.1186/1477-5956-9-68

Ejemplares similares